About
Overview
Learn More
Founders
- Dr. Walter Gilbert Ph.D.
- Dr. Stuart B. Levy M.D.
Executive Team
Management Team
- Randy Brenner
- More >>
Board of Directors
Science
Overview
Learn More
Omadacycline
- An oral and IV once-daily antibiotic agent with broad-spectrum activity directed against serious community acquired bacterial infections...
- More >>
Sarecycline
- An oral once-daily antibiotic agent with a narrow spectrum of antibacterial activity and anti-inflammatory properties that is being evaluated...
- More >>
Clinical Trials
Insights
Overview
Learn More
Needs
Corporate Highlights
Publications
Overview
Learn More
Presentation
- Corporate PresentationDownload as PDF
- More >>
Medical Conferences
- Bibliography Omadacycline
- More >>
Manuscripts
- Structure-Activity Relationship of the Aminomethylcyclines and Discovery of Omadacycline
- More >>
Investor Relations
Corporate Presentation
Corporate Governance
Stock Information
SEC Filings
- Section 16 Filings (3,4,5)
News
- Paratek Pharmaceuticals News
- Transcept Pharmaceutical Archives
Events & Presentations
- Past Events
Information Request
- Investor FAQs
Careers
Overview
Learn More
The Team
- Testimonials
- More >>
Positions Available
- More >>
Apply Now
- Application Form
- More >>
Contact

Stock Quote & Chart

PRTK (Common Stock)
Price	Change	% Change	Volume
$24.25	+ 0.50	2.11%	244,982
Previous Close	Today's Open	Intraday High	Intraday Low
$23.75	$23.80	$24.38	$23.55
Exchange: NASDAQ (US Dollar)
10/17/17 4:00 p.m. ET

Data provided by Nasdaq. Minimum 15 minutes delayed.

Talk with the Paratek Team

Send us an inquiry by submitting a form directly on the site or give us a call.